Principia Biopharma Inc (PRNB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PRNB Annual Balance Sheets →
Examining balance sheet movements between Principia Biopharma Inc and Jun 30 2019 reveals how Jun 30 2020 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2020)
(Mar 31 2020) (Dec 31 2019) (Sep 30 2019) (Jun 30 2019)
Assets
Cash & cash equivalent170.49
Marketable Securities, Current SH146.05
Cash & Short-term Investments316.00
Prepaid Expense And Other Assets Current52.89
Total Current Assets369.42
Equipment/Property/Plant Net9.00
Long-term investments0.00
Other Assets, Noncurrent7.00
Restricted Cash Noncurrent0.57
Total Assets385.95
Liabilities
Accounts Payable, Current AC1.24
Accrued Liabilities, Current5.83
Other Liabilities, Current14.64
Deferred Rent Credit, Current DE0.00
Total Current Liabilities21.71
Total Long-term Debt0.00
Deferred Rent Credit, Noncurrent DE0.00
Other liabilities, Noncurrent0.00
Accrued Research And Development Liability Current12.74
Operating Lease Liability Noncurrent12.80
Total Liabilities34.51
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock558.54
Retained Earnings / Accumulated Deficit-207.43
Other Equity0.33
Common Stockholder's Equity351.44
Total Stockholder's Equity351.44
Liabilities & Stockholder's Equity385.95
4 historic quarters locked

Sign in to unlock the full Principia Biopharma Inc balance sheet history.

About PRNB Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.